The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Injectable Drug Delivery-Global Market Insights and Sales Trends 2024
Synopsis
Injectable drug delivery is defined as introduction of a drug or drugs in the patient by using a delivery device. Injectables allow the transport of drugs formulated in liquid form, directly in the body. Even though, they may be designed to transport the drug to specific part of the body.
The global Injectable Drug Delivery market size is expected to reach US$ 675.5 million by 2029, growing at a CAGR of 6.5% from 2023 to 2029. The market is mainly driven by the significant applications of Injectable Drug Delivery in various end use industries. The expanding demands from the Hospitals & Clinics, Home Care Settings and Others,, are propelling Injectable Drug Delivery market. Skin Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Circulatory/Musculoskeletal Injection segment is estimated at % CAGR for the next seven-year period.
North America is expected to dominate the market in 2018, Asia is expected to grow at the highest CAGR during the forecast period. This growth in this market is attributed to rising incidence of chronic diseases and growing aging population. In addition, high penetration of self-injection technologies in Asian countries such as China, Japan, and India adds to the demand for injectable devices.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Injectable Drug Delivery, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Injectable Drug Delivery market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Injectable Drug Delivery market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Injectable Drug Delivery sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Injectable Drug Delivery covered in this report include Baxter, Becton, Dickinson, Gerresheimer, Pfizer, Schott, ELI Lilly, Novartis, Terumo and Teva Pharmaceutical, etc.
The global Injectable Drug Delivery market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Baxter
Becton, Dickinson
Gerresheimer
Pfizer
Schott
ELI Lilly
Novartis
Terumo
Teva Pharmaceutical
Global Injectable Drug Delivery market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Injectable Drug Delivery market, Segment by Type:
Skin Injection
Circulatory/Musculoskeletal Injection
Organs Injection
Central Nervous System Injection
Global Injectable Drug Delivery market, by Application
Hospitals & Clinics
Home Care Settings
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Injectable Drug Delivery companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Injectable drug delivery is defined as introduction of a drug or drugs in the patient by using a delivery device. Injectables allow the transport of drugs formulated in liquid form, directly in the body. Even though, they may be designed to transport the drug to specific part of the body.
The global Injectable Drug Delivery market size is expected to reach US$ 675.5 million by 2029, growing at a CAGR of 6.5% from 2023 to 2029. The market is mainly driven by the significant applications of Injectable Drug Delivery in various end use industries. The expanding demands from the Hospitals & Clinics, Home Care Settings and Others,, are propelling Injectable Drug Delivery market. Skin Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Circulatory/Musculoskeletal Injection segment is estimated at % CAGR for the next seven-year period.
North America is expected to dominate the market in 2018, Asia is expected to grow at the highest CAGR during the forecast period. This growth in this market is attributed to rising incidence of chronic diseases and growing aging population. In addition, high penetration of self-injection technologies in Asian countries such as China, Japan, and India adds to the demand for injectable devices.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Injectable Drug Delivery, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Injectable Drug Delivery market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Injectable Drug Delivery market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Injectable Drug Delivery sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Injectable Drug Delivery covered in this report include Baxter, Becton, Dickinson, Gerresheimer, Pfizer, Schott, ELI Lilly, Novartis, Terumo and Teva Pharmaceutical, etc.
The global Injectable Drug Delivery market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Baxter
Becton, Dickinson
Gerresheimer
Pfizer
Schott
ELI Lilly
Novartis
Terumo
Teva Pharmaceutical
Global Injectable Drug Delivery market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Injectable Drug Delivery market, Segment by Type:
Skin Injection
Circulatory/Musculoskeletal Injection
Organs Injection
Central Nervous System Injection
Global Injectable Drug Delivery market, by Application
Hospitals & Clinics
Home Care Settings
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Injectable Drug Delivery companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Injectable Drug Delivery
1.1 Injectable Drug Delivery Market Overview
1.1.1 Injectable Drug Delivery Product Scope
1.1.2 Injectable Drug Delivery Market Status and Outlook
1.2 Global Injectable Drug Delivery Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Injectable Drug Delivery Market Size by Region (2018-2029)
1.4 Global Injectable Drug Delivery Historic Market Size by Region (2018-2023)
1.5 Global Injectable Drug Delivery Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Injectable Drug Delivery Market Size (2018-2029)
1.6.1 North America Injectable Drug Delivery Market Size (2018-2029)
1.6.2 Europe Injectable Drug Delivery Market Size (2018-2029)
1.6.3 Asia-Pacific Injectable Drug Delivery Market Size (2018-2029)
1.6.4 Latin America Injectable Drug Delivery Market Size (2018-2029)
1.6.5 Middle East & Africa Injectable Drug Delivery Market Size (2018-2029)
2 Injectable Drug Delivery Market by Type
2.1 Introduction
2.1.1 Skin Injection
2.1.2 Circulatory/Musculoskeletal Injection
2.1.3 Organs Injection
2.1.4 Central Nervous System Injection
2.2 Global Injectable Drug Delivery Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Injectable Drug Delivery Historic Market Size by Type (2018-2023)
2.2.2 Global Injectable Drug Delivery Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Injectable Drug Delivery Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Injectable Drug Delivery Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Injectable Drug Delivery Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Injectable Drug Delivery Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Injectable Drug Delivery Revenue Breakdown by Type (2018-2029)
3 Injectable Drug Delivery Market Overview by Application
3.1 Introduction
3.1.1 Hospitals & Clinics
3.1.2 Home Care Settings
3.1.3 Others
3.2 Global Injectable Drug Delivery Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Injectable Drug Delivery Historic Market Size by Application (2018-2023)
3.2.2 Global Injectable Drug Delivery Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Injectable Drug Delivery Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Injectable Drug Delivery Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Injectable Drug Delivery Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Injectable Drug Delivery Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Injectable Drug Delivery Revenue Breakdown by Application (2018-2029)
4 Injectable Drug Delivery Competition Analysis by Players
4.1 Global Injectable Drug Delivery Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Injectable Drug Delivery as of 2022)
4.3 Date of Key Players Enter into Injectable Drug Delivery Market
4.4 Global Top Players Injectable Drug Delivery Headquarters and Area Served
4.5 Key Players Injectable Drug Delivery Product Solution and Service
4.6 Competitive Status
4.6.1 Injectable Drug Delivery Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Baxter
5.1.1 Baxter Profile
5.1.2 Baxter Main Business
5.1.3 Baxter Injectable Drug Delivery Products, Services and Solutions
5.1.4 Baxter Injectable Drug Delivery Revenue (US$ Million) & (2018-2023)
5.1.5 Baxter Recent Developments
5.2 Becton, Dickinson
5.2.1 Becton, Dickinson Profile
5.2.2 Becton, Dickinson Main Business
5.2.3 Becton, Dickinson Injectable Drug Delivery Products, Services and Solutions
5.2.4 Becton, Dickinson Injectable Drug Delivery Revenue (US$ Million) & (2018-2023)
5.2.5 Becton, Dickinson Recent Developments
5.3 Gerresheimer
5.3.1 Gerresheimer Profile
5.3.2 Gerresheimer Main Business
5.3.3 Gerresheimer Injectable Drug Delivery Products, Services and Solutions
5.3.4 Gerresheimer Injectable Drug Delivery Revenue (US$ Million) & (2018-2023)
5.3.5 Pfizer Recent Developments
5.4 Pfizer
5.4.1 Pfizer Profile
5.4.2 Pfizer Main Business
5.4.3 Pfizer Injectable Drug Delivery Products, Services and Solutions
5.4.4 Pfizer Injectable Drug Delivery Revenue (US$ Million) & (2018-2023)
5.4.5 Pfizer Recent Developments
5.5 Schott
5.5.1 Schott Profile
5.5.2 Schott Main Business
5.5.3 Schott Injectable Drug Delivery Products, Services and Solutions
5.5.4 Schott Injectable Drug Delivery Revenue (US$ Million) & (2018-2023)
5.5.5 Schott Recent Developments
5.6 ELI Lilly
5.6.1 ELI Lilly Profile
5.6.2 ELI Lilly Main Business
5.6.3 ELI Lilly Injectable Drug Delivery Products, Services and Solutions
5.6.4 ELI Lilly Injectable Drug Delivery Revenue (US$ Million) & (2018-2023)
5.6.5 ELI Lilly Recent Developments
5.7 Novartis
5.7.1 Novartis Profile
5.7.2 Novartis Main Business
5.7.3 Novartis Injectable Drug Delivery Products, Services and Solutions
5.7.4 Novartis Injectable Drug Delivery Revenue (US$ Million) & (2018-2023)
5.7.5 Novartis Recent Developments
5.8 Terumo
5.8.1 Terumo Profile
5.8.2 Terumo Main Business
5.8.3 Terumo Injectable Drug Delivery Products, Services and Solutions
5.8.4 Terumo Injectable Drug Delivery Revenue (US$ Million) & (2018-2023)
5.8.5 Terumo Recent Developments
5.9 Teva Pharmaceutical
5.9.1 Teva Pharmaceutical Profile
5.9.2 Teva Pharmaceutical Main Business
5.9.3 Teva Pharmaceutical Injectable Drug Delivery Products, Services and Solutions
5.9.4 Teva Pharmaceutical Injectable Drug Delivery Revenue (US$ Million) & (2018-2023)
5.9.5 Teva Pharmaceutical Recent Developments
6 North America
6.1 North America Injectable Drug Delivery Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Injectable Drug Delivery Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Injectable Drug Delivery Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Injectable Drug Delivery Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Injectable Drug Delivery Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Injectable Drug Delivery Market Dynamics
11.1 Injectable Drug Delivery Industry Trends
11.2 Injectable Drug Delivery Market Drivers
11.3 Injectable Drug Delivery Market Challenges
11.4 Injectable Drug Delivery Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
